Abstract 174P
Background
Application of computer and artificial intelligence (AI) has made revolutionary progress in medical fields. Computer-assisted diagnosis (CAD) on pathology is successful in diagnosis, classification, staging and predicting prognosis of cancer.
Methods
In this work, we used the technique of convolutional neural networks (CNN) for training of morphological images of gastric cancer, which is a promising application of artificial intelligence technique for medical image analysis, especially for cancer pathology.
Results
We introduced successful works of AI-aided gastric cancer analysis for over 300 cases. AI-assisted pathology technique could help the pathologist in detecting and locating the abnormal area in images and to diagnose and classify benign or malignant tissues. Therefore, AI exactly improves the diagnostic status of gastric cancer, such as in interpretation of medical images and classification between benign and cancerous tissues. The complete workflow of AI diagnosis for gastric cancer is under construction. AI is more useful in releasing pathologists from repeated work, and improving efficiency.
Conclusions
In conclusions, there are still notable technical obstacles before this approach can be used to improve conventional clinical practice. Higher performance needs corrected marking images by experienced pathologist and require ‘training’ algorithms on tremendous data. We stressed the importance of proper algorithms for improving confidence of analytic results that is close to human experts. Additionally, we indicated the gaps in current research and principal resolutions for advancing the field.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors without further recourse to the authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
274P - Treatment stratification of non-Hodgkin large B-cell lymphoma patients based on the identification of mutational c-MYC gene
Presenter: Raimkul Karakulov
Session: Poster display session
Resources:
Abstract
275P - Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: Preliminary results in Vietnam
Presenter: Gia Nguyen Hoang
Session: Poster display session
Resources:
Abstract
276P - Chronic myelod leukemia in chronic phase (CML-CP) with lymphadenopathy at diagnosis: A retrospective analysis
Presenter: GEDALA Veni Prasanna
Session: Poster display session
Resources:
Abstract
277P - Characteristics of BCR-ABL rearrangement variants in Pakistani patients with chronic myeloid leukemia and acute lymphocytic leukemia
Presenter: Zeeshan Ahmed
Session: Poster display session
Resources:
Abstract
278P - A systematic literature review of the cost-effectiveness of treatments, costs, and resource use in patients with Burkitt lymphoma
Presenter: Gautamjeet Mangat
Session: Poster display session
Resources:
Abstract
280P - Risk stratification of CML-CP in a real-world scenario, comparison of S.H.E. with rate of fall of BCR/ABL
Presenter: Kundan Mishra
Session: Poster display session
Resources:
Abstract
281P - Selective depletion of tumour-associated SAMHD1 by HSP90 inhibitors enhances the anti-AML effect of cytarabine
Presenter: Jing Sun
Session: Poster display session
Resources:
Abstract
282P - Inhibition of miR-144 and miR-199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling
Presenter: Nidh Gupta
Session: Poster display session
Resources:
Abstract
283P - Effect of study-level factors on treatment-free remission rate in patients with chronic myeloid leukemia: A systematic review and meta-analysis
Presenter: Jinhyun Cho
Session: Poster display session
Resources:
Abstract
284P - Differences in disease characteristics and survival outcomes of follicular lymphoma in young adults and older population: An institutional analysis
Presenter: Shina Goyal
Session: Poster display session
Resources:
Abstract